Literature DB >> 2343077

A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation.

J F Deakin1, I Pennell, A J Upadhyaya, R Lofthouse.   

Abstract

To investigate whether depression is a consequence of disturbed function in 5HT systems, neuroendocrine responses to infusions of the 5HT precursor L-tryptophan (LTP) were studied in patients and controls. After an overnight fast and 60 min bed rest, a solution of LTP (10 g/l) was infused intravenously to a dose of 100 mg/kg over 30 min. Circulating growth hormone (GH), prolactin (PRL), cortisol and tryptophan concentrations were followed from 60 min pre-infusion to 60 min post-infusion. GH responses were attenuated in 23 major depressives (DSM-III) compared with 22 controls and were almost absent in endogenous depressives (New-castle criteria). PRL responses were normal in depressives who had lost more than 3 kg body weight but attenuated in those who had not. GH and PRL responses did not correlate with each other. Reduced basal tryptophan concentrations and more rapid tryptophan clearance were observed in the depressives, but there were no correlations with GH or PRL responses. However, basal cortisol concentrations, which were raised in depressives with chronic psychosocial difficulties, were strongly and inversely predictive of PRL responses in depressives and controls. Blunted GH and PRL responses to LTP appear to be distinct abnormalities in depression which may relate to two processes; (1), an endogenous mechanism indicated by reduced GH responses, and (2), an impairment in 5HT systems, indicated by blunted PRL responses and perhaps caused by raised circulating cortisol or reduced tryptophan concentrations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2343077     DOI: 10.1007/bf02253723

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.

Authors:  F K Goodwin; R M Post; D L Dunner; E K Gordon
Journal:  Am J Psychiatry       Date:  1973-01       Impact factor: 18.112

2.  Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

Authors:  H R Bourne; W E Bunney; R W Colburn; J M Davis; J N Davis; D M Shaw; A J Coppen
Journal:  Lancet       Date:  1968-10-12       Impact factor: 79.321

3.  5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis.

Authors:  R Sjöström; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

4.  Corticosterone modulation of neurotransmitter receptors in rat hippocampus: a quantitative autoradiographic study.

Authors:  A Biegon; T C Rainbow; B S McEwen
Journal:  Brain Res       Date:  1985-04-22       Impact factor: 3.252

5.  Clomipramine enhances prolactin and growth hormone responses to L-tryptophan.

Authors:  I M Anderson; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Selective control by corticosterone of serotonin1 receptor capacity in raphe-hippocampal system.

Authors:  E R De Kloet; H Sybesma; H M Reul
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

7.  "Serotonin depression"--a biochemical subgroup within the affective disorders?

Authors:  M Asberg; P Thorén; L Träskman; L Bertilsson; V Ringberger
Journal:  Science       Date:  1976-02-06       Impact factor: 47.728

8.  Reduced-5-hydroxytryptamine-dependent behavior in rats following chronic corticosterone treatment.

Authors:  S L Dickinson; G A Kennett; G Curzon
Journal:  Brain Res       Date:  1985-10-14       Impact factor: 3.252

9.  The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers. Important implications for neuroendocrine investigations in depression.

Authors:  G M Goodwin; C G Fairburn; P J Cowen
Journal:  Arch Gen Psychiatry       Date:  1987-11

10.  Neuroendocrine responses to intravenous tryptophan in major depression.

Authors:  P J Cowen; E M Charig
Journal:  Arch Gen Psychiatry       Date:  1987-11
View more
  17 in total

1.  Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response.

Authors:  M Maes; R Verkerk; E Vandoolaeghe; F Van Hunsel; H Neels; A Wauters; P Demedts; S Scharpé
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 2.  The 5-HT receptor--G-protein--effector system complex in depression. I. Effect of glucocorticoids.

Authors:  K P Lesch; B Lerer
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 3.  Affective cognition and its disruption in mood disorders.

Authors:  Rebecca Elliott; Roland Zahn; J F William Deakin; Ian M Anderson
Journal:  Neuropsychopharmacology       Date:  2010-06-23       Impact factor: 7.853

Review 4.  5-HT-HPA interactions in two models of transgenic mice relevant to major depression.

Authors:  L Lanfumey; C Mannoury La Cour; N Froger; M Hamon
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

5.  Neurotransmitter Systems in a Mild Blast Traumatic Brain Injury Model: Catecholamines and Serotonin.

Authors:  Lizan Kawa; Ulf P Arborelius; Takashi Yoshitake; Jan Kehr; Tomas Hökfelt; Mårten Risling; Denes Agoston
Journal:  J Neurotrauma       Date:  2015-04-01       Impact factor: 5.269

6.  Pindolol decreases prolactin and growth hormone responses to intravenous L-tryptophan.

Authors:  C E Smith; C J Ware; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Elevated prolactin responses to L-tryptophan infusion in medication-free depressed patients.

Authors:  Richard J Porter; Peter Gallagher; Stuart Watson; Margaret S Smith; Allan H Young
Journal:  Psychopharmacology (Berl)       Date:  2003-05-01       Impact factor: 4.530

8.  Alteration in plasma corticosterone levels following long term oral administration of lead produces depression like symptoms in rats.

Authors:  Saida Haider; Sadia Saleem; Saiqa Tabassum; Saima Khaliq; Saima Shamim; Zehra Batool; Tahira Parveen; Qurat-ul-ain Inam; Darakhshan J Haleem
Journal:  Metab Brain Dis       Date:  2013-01-12       Impact factor: 3.584

Review 9.  Corticosteroid-serotonin interactions in depression: a review of the human evidence.

Authors:  Richard J Porter; Peter Gallagher; Stuart Watson; Allan H Young
Journal:  Psychopharmacology (Berl)       Date:  2004-03-09       Impact factor: 4.530

10.  Crossroads of corticotropin releasing hormone, corticosteroids and monoamines. About a biological interface between stress and depression.

Authors:  H. M. Van Praag
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.